Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-31T13:37:31.682Z Has data issue: false hasContentIssue false
  • English
  • Français

Elimination of mycoplasmas from the murine genital tract by hormone treatment

Published online by Cambridge University Press:  15 May 2009

D. Taylor-Robinson  and
P. M. Furr
D. Taylor-Robinson
Affiliation:
Division of Sexually Transmitted Diseases, MRC Clinical Research Centre, Watford Road, Harrow, Middlesex HA1 3UJ
P. M. Furr
Affiliation:
Division of Sexually Transmitted Diseases, MRC Clinical Research Centre, Watford Road, Harrow, Middlesex HA1 3UJ
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Twenty progesterone-treated TO mice were infected intravaginally with Mycoplasma pulmonis. One month later, ten of the mice were given oestradiol which changed the reproductive cycle to the oestrous phase and within a week resulted in eradication of the organisms from six of them; vaginal persistence in the other mice may have been due, at least in part, to reinoculation of organisms from the oropharynx, a site heavily infected in all the mice. The majority of the mice not treated with oestradiol continued to shed the organisms from the vagina for at least 91 days. In another experiment, 19 oestradiol-treated BALB/c mice were infected intravaginally with M. hominis. One month later, nine of the mice were given progesterone which changed the reproductive cycle to the dioestrous phase and eradicated the organisms from seven within 2 weeks and from all of them within about a month. This was in contrast to the mice not given progesterone, the majority of which continued to shed the organisms for at least 167 days.

Type
Special Article
Information
Epidemiology & Infection , Volume 105 , Issue 1 , August 1990 , pp. 163 - 168
Copyright
Copyright © Cambridge University Press 1990

References

REFERENCES

1.Furr, PM, Taylor-Robinson, D. Enhancement of experimental Mycoplasma pulmonis infection of the mouse genital tract by progesterone treatment. J Hyg 1984; 92: 139–44.CrossRefGoogle ScholarPubMed
2.Taylor-Robinson, D, Furr, PM. The interplay of host and organism factors in infection of the mouse genital tract by Mycoplasma pulmonis. J Hyg 1985; 95: 7–14.CrossRefGoogle ScholarPubMed
3.Furr, PM, Taylor-Robinson, D. The establishment and persistence of Ureaplasma urealyticum in oestradiol-treated female mice. J Med Microbiol 1989; 29: 111–14.CrossRefGoogle ScholarPubMed
4.Furr, PM, Taylor-Robinson, D. Oestradiol-induced Mycoplasma hominis infection of the genital tract of female mice. J Gen Microbiol 1989; 135: 2743–9.Google ScholarPubMed
5.Furr, PM, Hetherington, CM, Taylor-Robinson, D. The susceptibility of germ-free, oestradioltreated, mice to Mycoplasma hominis. J Med Microbiol 1989; 30: 233–6.CrossRefGoogle ScholarPubMed
6.Manchee, RJ, Taylor-Robinson, D. Haemadsorption and haemagglutination by mycoplasmas. J Gen Microbiol 1968; 50: 465–78.CrossRefGoogle ScholarPubMed
7.Rugh, R. The mouse. Its reproduction and development. Minneapolis: Burgess Publishing Co. 1968: 38–9.Google Scholar
8.Taylor-Robinson, D, Munday, PE. Mycoplasmal infection of the female genital tract and its complications. In: Hare, MJ, ed. Genital tract infections in women. Edinburgh: Churchill Livingstone 1988: 228–47.Google ScholarPubMed